|108.23||+1.21||+1.13%||Vol 275.96K||1Y Perf 31.30%|
|Sep 15th, 2021 16:00 DELAYED|
|- -%||- -|
|Target Price||181.33||Analyst Rating||Moderate Buy 2.33|
|Potential %||67.54||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||— -|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||39.75||Earnings Rating||Buy|
|Market Cap||5.84B||Earnings Date||8th Nov 2021|
Today's Price Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||8th Nov 2021|
|Estimated EPS Next Report||-1.12|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||260.53K|
|Avg. Monthly Volume||220.71K|
|Avg. Quarterly Volume||272.32K|
Allakos Inc. (NASDAQ: ALLK) stock closed at 108.23 per share at the end of the most recent trading day (a 1.13% change compared to the prior day closing price) with a volume of 279.73K shares and market capitalization of 5.84B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 114 people. Allakos Inc. CEO is Robert Alexander.
The one-year performance of Allakos Inc. stock is 31.3%, while year-to-date (YTD) performance is -22.69%. ALLK stock has a five-year performance of %. Its 52-week range is between 75.41 and 157.98, which gives ALLK stock a 52-week price range ratio of 39.75%
Allakos Inc. currently has a PE ratio of -27.50, a price-to-book (PB) ratio of 9.96, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -34.46%, a ROC of -37.22% and a ROE of -38.20%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Allakos Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-1.12 for the next earnings report. Allakos Inc.’s next earnings report date is 08th Nov 2021.
The consensus rating of Wall Street analysts for Allakos Inc. is Moderate Buy (2.33), with a target price of $181.33, which is +67.54% compared to the current price. The earnings rating for Allakos Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Allakos Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Allakos Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.29, ATR14 : 3.76, CCI20 : 124.96, Chaikin Money Flow : 0.38, MACD : 6.35, Money Flow Index : 100.00, ROC : 25.47, RSI : 82.56, STOCH (14,3) : 95.37, STOCH RSI : 1.00, UO : 65.57, Williams %R : -4.63), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Allakos Inc. in the last 12-months were: Adam Tomasi (Option Excercise at a value of $280 463), Adam Tomasi (Sold 349 507 shares of value $37 788 375 ), Daniel S. Janney (Sold 47 341 shares of value $5 669 135 ), Henrik S. Rasmussen (Option Excercise at a value of $127 875), Henrik S. Rasmussen (Sold 111 952 shares of value $12 905 844 ), John P. Mckearn (Sold 7 439 shares of value $855 485 ), Robert Alexander (Option Excercise at a value of $106 726), Robert Alexander (Sold 103 550 shares of value $11 682 246 ), Steven P. James (Option Excercise at a value of $1 838), Steven P. James (Sold 3 500 shares of value $425 775 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.